New Zealand Cervical Cancer Experiment

16
“The Unfortunate Experiment” a very abbreviated tale Rachel Walden

description

Brief overview of Dr. Herbert Green's "unfortunate experiment" on New Zealand women with cervical abnormalities (please excuse the abundant text and lack of images)

Transcript of New Zealand Cervical Cancer Experiment

Page 1: New Zealand Cervical Cancer Experiment

“The Unfortunate Experiment”a very abbreviated tale

Rachel Walden

Page 2: New Zealand Cervical Cancer Experiment

Cervical Cancera few terms, courtesy of the NCI

Cervical cancer: Cancer that forms in tissues of the cervix (organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms, but can be found with regular Pap smears (procedure in which cells are scraped from the cervix and looked at under a microscope).

Stage 0: The cancer is found only in the top layer of cells in the tissue that lines the cervix. Stage 0 is also called carcinoma in situ. Properly treated, tumor control of in situ cervical carcinoma should be nearly 100%.

Punch biopsy: a sharp, hollow device is used to remove sample of cervical tissue.

Cone biopsy: removes a cone-shaped sample of tissue.

Page 3: New Zealand Cervical Cancer Experiment

The Experiment

Conducted at National Women’s Hospital, Auckland, New Zealand

Headed by Dr. Herbert Green, OB/GYN at NWH, professor

948 patients with carcinoma in situ (CIS) of the cervix

Women followed from 1955 to 1976; study officially began in 1966

To prove that CIS never develops into invasive cervical cancer, is not a premalignant condition

To reduce number of major/invasive procedures to treat CIS, such as hysterectomy

Page 4: New Zealand Cervical Cancer Experiment

The Methodology

NWH patients recruited with cervical CIS who were under 35 yo, there were to be no signs of invasive carcinoma

Followed from 5 to 28 years

Split into groups by normal (A) or abnormal (B) cytology at follow up

Received cone biopsies and other diagnostic procedures – not complete cancer removal

Page 5: New Zealand Cervical Cancer Experiment

The Results

1.5% of group A and 22% of group B developed invasive cancer

Women with continuing abnormal cytology 24.8 times more likely to develop invasive carcinoma

In group A (normal follow-up), 3.2 times more likely to develop cancer than women who never had CIS

Some women later died

Green reclassified some of those who developed invasive cancer as having been missed initially

Page 6: New Zealand Cervical Cancer Experiment

The Controversy

In 1987, women’s health activists published an article, “An Unfortunate Experiment,” in the Metro magazine outlining the study. This article focused on one patient, “Ruth,” who was followed from 1964 to 1979, and finally diagnosed with cervical cancer in 1985.

Public outcry occurred, and judicial inquiry ordered by the Ministry of Health

Cartwright inquiry – officially, “Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters,” headed by District Court Judge Silvia Cartwright

67 witnesses heard and >80 patients interviewed privately

Report released August 5, 1988

Page 7: New Zealand Cervical Cancer Experiment

The Inquiry Findings

Determined that the study was unethical: women not informed they were in a study; not informed of other treatment options; inadequately addressed risks to patients; symptoms of invasive disease downplayed or overlooked; some women never even told they had CIS

Dr. Green maintained it was not in the women’s interests to tell them what he was doing

Other revelations: medical students were doing vaginal exams on anaesthetized women without their knowledge or consent; >2,000 newborn females received cervical smears; some women later enrolled in R Series trial of differing treatments of invasive cancer without their knowledge

Page 8: New Zealand Cervical Cancer Experiment

The Inquiry, continued

Early attempts at questioning the by the cytologist and pathologist program went nowhere – Superintendent-in-Chief of the Auckland Medical Board did not consider the matter “urgent”

Other clinicians did not want to interfere with Dr. Green’s “clinical freedom”

Cases of invasive cancer were identified in 1969, but trial continued

Enrollment protocol not followed – women over 35 were included fairly regularly, invasive signs ignored

Numerous recommendations for improvement: patient advocates, nationwide cervical cancer screening, improved informed consent, ethics

Page 9: New Zealand Cervical Cancer Experiment

Women’s Statements

“I can’t explain the shock that I felt when I found out by accident that I had a cone biopsy.”

“…I was never actually told that I had carcinoma in situ.”

“After I had the cone biopsy I was told that they had got it all. I have since learnt that this was not the case. I was told that the chance of getting any form of cancer again were the same as any other woman.”

“For instance, if I had known that my biopsy in 1975 showed that I had microinvasion, I would never have ceased to go to follow-up clinics.”

Page 10: New Zealand Cervical Cancer Experiment

Historical Context

Declaration of Helsinki written in 1964; Nuremburg Code also in existence at time of study

According to the Cartwright report: “By the early 1960s most experts in Europe, the United States of America and Australia considered that CIS was a precursor of invasive cervical cancer.”

Indirect and direct evidence was in existence when study began that CIS could in fact lead to invasive cancer

Less invasive management techniques were already gaining favor before 1966

Page 11: New Zealand Cervical Cancer Experiment

The Aftermath~130 patients identified and contacted for follow-up. This was not perfect, as follow-up sometimes occurred in the course of routine clinical care, without women being provided with full details of their past enrollment into Dr. Green’s study

Bureaucracy and resistance slows action on Cartwright report recommendations. Some physicians call informed consent procedures too burdensome.

Cartwright Inquiry challenged, attacked as a “feminist witch hunt,” but later vindicated

Some physicians investigated and fined. Dr. Green not punished due to poor health. Several women sue and receive damages.

In the 1990s a related inquiry occurs, after it is found that abnormal cervical smear results have been vastly underreported in one region of the national cervical cancer screening program. More women die of cervical cancer as a result.

Page 12: New Zealand Cervical Cancer Experiment

SummaryStudy based on personal beliefs rather than established facts

Informed consent – completely absent

Lack of understanding and voluntariness

Respect for persons – individuals not treated as autonomous agents

Justice – subjects were chosen because they were available

Beneficence – no efforts to minimize harm

Questionable handling of adverse events

Institutional safeguards broken/not followed

Hypothesis disproved; trial continued

Page 13: New Zealand Cervical Cancer Experiment

Resources

Campbell AV. A report from New Zealand: an ‘unfortunate experiment.’ Bioethics. 1989 Jan;3(1):59-66.

Committee on Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Report of the Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Auckland: The Committee, 1988.

Davis P. A fortunate inquest: the report of the cervical cancer inquiry. Community Health Stud. 1988;12(3):246-50.

Coney S, ed. Unfinished business: what happened to the Cartwright Report?: writings on the aftermath of 'the unfortunate experiment' at National Women's Hospital. Auckland: Women’s Health Action, 1993.

Coney S. The Unfortunate Experiment. Auckland: Penguin Books, 1988.

Page 14: New Zealand Cervical Cancer Experiment

Resources - 2

Flagler EA, Winkler ER. ‘An unfortunate experiment’: the New Zealand study of cancer of the cervix. Ann R Coll Physicians Surg Can. 1992 Apr;25(2):124-30.

Heslop B. ‘All about research’ – looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Aug 6;117(1199):U1000.

McIndoe WA, McLean MR, Jones RW, Mullins PR. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol. 1984 Oct;64(4):451-8.

Munro K. The aftermath of the cervical caner inquiry in New Zealand: an antipodal aberration or universal struggle? Issues Reprod Genet Eng. 1991;4(1):31-9.

Paul C. Internal and external morality of medicine: lessons from New Zealand. BMJ. 2000 Feb;320(7233):499-503.

Page 15: New Zealand Cervical Cancer Experiment

Resources - 3

Rosier P. The speculum bites back: feminists spark an inquiry into the treatment of carcinoma in situ at Auckland’s National Women’s Hospital. Reprod Genet Eng. 1989;2(2):121-32.

Williams L. Looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Sep 24;117(1202):U1084; author reply U1084.

Women’s Health Action Trust. Women’s Health Action [web document]. Auckland: The Trust. [rev. 28 Dec 2005; cited 18 Apr 2006]. <http://www.womens-health.org.nz/>

Page 16: New Zealand Cervical Cancer Experiment

Special Thanks

to the EBL Document Delivery staff

These amazing folks obtained a copy of the Cartwright Report, held by fewer than 20 libraries in the United States!